The financing will enable pre-clinical development of VLX-ADC-001, a LIV-1-targeting ADC for metastatic triple-negative ...

In this video tutorial, we will learn how to solve quadratic equations by factoring, completing the square, and using the quadratic formula. We will first start off by working through factoring ...

Merck & Co., Inc. (NYSE:MRK) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some, now well below its 52-week high of $125.14.

Learn how to write the equation of hyperbolas given the characteristics of the hyperbolas. The standard form of the equation of a hyperbola is of the form: (x - h)^2 / a^2 - (y - k)^2 / b^2 = 1 for ...

ALX Oncology (NASDAQ:ALXO) outlined progress across its two core programs—CD47 blocker evorpacept and EGFR-targeted ...

In its preliminary guidance, NICE said it had concerns about the economic model proposed by Genmab to make the case for Tivdak's use by the NHS as a second-line therapy for cervical cancer, so it was ...

The move comes as BioNTech shifts to being a multiproduct commercial biotech, allowing Ugur Sahin and Özlem Türeci to transition back into research on next-generation mRNA therapeutics.

A licensing structure assigns SteinCares end-to-end Latin America market execution while Shilpa retains development and sustained commercial supply responsibilities. The collaboration targets wider ...

Joseph Ladapo made national news when he said he wanted to abolish all school vaccine mandates, but the Legislature never ...

KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.

When alpine skier Mikaela Shiffrin casually dropped a video showing what she jokingly called her “back abs,” the internet predictably lost its collective mind. The clip shows etched lines and ...

HUTCHMED (NASDAQ:HCM) management used its 2025 annual results call to highlight growth in global sales for FRUZAQLA, a ...